Rx-To-OTC Switch Guidance May Be Issued By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA's Division of OTC Drug Products is considering issuing a guidance on the type of data that should be included in an NDA supporting an Rx-to-OTC switch